Clinical Chemistry Link to Randox Laboratories Web Site
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 24: 927-930, 1978;
This Article
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Stryd, R. P.
Right arrow Articles by Gilbertson, T. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Stryd, R. P.
Right arrow Articles by Gilbertson, T. J.

Clinical Chemistry, Vol 24, 927-930, Copyright © 1978 by American Association for Clinical Chemistry

Some problems in development of a high-performance liquid chromatographic assay to measure 25-hydroxyvitamin D2 and 25- hydroxyvitamin D3 simultaneously in human serum

RP Stryd and TJ Gilbertson

A high-performance liquid chromatographic technique was examined that may allow simultaneous measurement of 25-hydroxyvitamin D2 and 25- hydroxyvitamin D3 in a single sample of human serum. Concentrations of 4 microgram/liter or greater are accurately measured. However, the prepurification procedure allows partial separation of the two metabolites, and so tritiated 25-hydroxyvitamin D3 can be used as an internal standard for accurately monitoring the analytical recovery of 25-hydroxyvitamin D3, but not that of 25-hydroxyvitamin D2. The ability of most prepurification procedures to partly separate the 25-hydroxy metabolites of vitamin D2 and D3 mandates the need for individual internal standards to accurately monitor the recovery of each compound. Values obtained for 25-hydroxyvitamin D2 or composite 25-hydroxyvitamin D when only tritiated 25-hydroxyvitamin D3 is used as a means of monitoring recovery are probably in error.




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1978 by the American Association for Clinical Chemistry.